Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 May 23 424B5 Prospectus supplement for primary offering
- 3 May 23 EFFECT Notice of effectiveness
-
17 Apr 23 S-3 Shelf registration
CARM similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated April 4, 2023, with respect to the consolidated financial statements of Carisma Therapeutics Inc., incorporated herein by reference and to the reference to our firm under the heading "Experts" in the prospectus.
/s/ KPMG LLP | |
Philadelphia, Pennsylvania | |
April 14, 2023 |